Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VPRIV safely and effectively. See full prescribing information for VPRIV. VPRIV® (velaglucerase alfa) for injection, for intravenous use Initial U.S. Approval: 2010
Medication labelWhy this: Advisory · dailymed-prescription
VPRIV is indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.
- generic_name
- velaglucerase alfa
- product_names
- velaglucerase alfa
- ndc
- 54092-701, 54092-701-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en